Nature of tumour rejection antigens in ovarian cancer

Muzamil Y Want1, Amit A Lugade1, Sebastiano Battaglia1

  • 1Center For Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Immunology
|May 18, 2018
PubMed

Insights

Identifying cancer-testis antigens and neoantigens in ovarian cancer is key for developing effective immunotherapies. This research focuses on selecting tumor rejection antigens to enhance T-cell-mediated cancer cell destruction.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Molecular characterization of human tumor antigens has advanced cancer immunotherapy.
  • Cancer-testis (CT) antigens are extensively studied in ovarian cancer due to their immunogenicity and restricted expression.
  • Elucidating tumor recognition mechanisms accelerates the development of immune-mediated tumor rejection strategies.

Purpose of the Study:

  • To review current strategies for selecting tumor rejection antigens in ovarian cancer.
  • To highlight the potential of neoantigens as specific immune targets for ovarian cancer immunotherapy.
  • To improve the efficacy of immunotherapy by identifying optimal immune targets.

Main Methods:

  • Review of preclinical and clinical studies on cancer-testis antigens in ovarian cancer.
  • Analysis of recent advancements in cancer sequencing technologies for neoantigen identification.
  • Evaluation of methods for selecting tumor mutations likely to be recognized by the immune system.

Main Results:

  • Cancer-testis antigens are promising targets for ovarian cancer immunotherapy.
  • Tumor mutations (neoantigens) identified through advanced sequencing can serve as specific immune targets.
  • Selection of appropriate tumor rejection antigens is crucial for enhancing immunotherapy efficacy.

Conclusions:

  • Targeting cancer-testis antigens and neoantigens holds significant potential for ovarian cancer treatment.
  • Advances in sequencing technologies enable precise identification of targets for T-cell-mediated tumor destruction.
  • Further research in selecting tumor rejection antigens will improve immunotherapy outcomes in ovarian cancer.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.4K
What is Natural Selection?01:32

What is Natural Selection?

Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
129.7K
Hypothesis: Accept or Fail to Reject?01:17

Hypothesis: Accept or Fail to Reject?

The outcome of any hypothesis testing leads to rejecting or not rejecting the null hypothesis. This decision is taken based on the analysis of the data, an appropriate test statistic, an appropriate confidence level, the critical values, and P-values. However, when the evidence suggests that the null hypothesis cannot be rejected, is it right to say, 'Accept' the null hypothesis?
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null...
29.6K
Quantifying and Rejecting Outliers: The Grubbs Test01:02

Quantifying and Rejecting Outliers: The Grubbs Test

Sometimes, a data set can have a recorded numerical observation that greatly  deviates from the rest of the data. Assuming that the data is normally distributed, a statistical method called the Grubbs test can be used to determine whether the observation is truly an outlier.  To perform a two-tailed Grubbs test, first, calculate the absolute difference between the outlier and the mean. Then, calculate the ratio between this difference and the standard deviation of the sample. This...
4.2K
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
4.1K
Chirality in Nature02:30

Chirality in Nature

Chirality is the most intriguing yet essential facet of nature, governing life’s biochemical processes and precision. It can be observed from a snail shell pattern in a macroscopic world to an amino acid, the minutest building block of life. Most of the snails around the world have right-coiled shells because of the intrinsic chirality in their genes. All the amino acids present in the human body exist in an enantiomerically pure state, except for glycine - the sole achiral amino acid.
17.3K